Clinical Trials Logo

Filter by:
NCT ID: NCT04757961 Completed - Depressive Symptoms Clinical Trials

Evaluation of an Acceptance and Commitment Therapy-Based Narrative Intervention for Individuals Taking Antidepressants

Start date: February 17, 2021
Phase: N/A
Study type: Interventional

This study aims to compare the efficacy of LifeStories on depression symptomatology compared to antidepressant treatment alone, in addition to examining the effect of the intervention on health-related quality of life. Participants will be randomly assigned to either an online ACT-based narrative intervention (Lifestories) or the waitlist control condition (antidepressant treatment alone). It is hypothesized that participants who receive the LifeStories will result in decreased depression and increased quality of life, general functioning and decreased psychological inflexibility compared to the waitlist group.

NCT ID: NCT04757948 Completed - Gagging Clinical Trials

Acupuncture vs TENS for Gag Reflex

Start date: June 13, 2018
Phase: N/A
Study type: Interventional

This study examines if acupuncture or TENS of P-6 and St-36 acupoints has a measurable effect on gag tolerance.

NCT ID: NCT04757935 Completed - Ulcerative Colitis Clinical Trials

Yoga for Youth With IBD: a Pilot Feasibility Study

Start date: January 1, 2017
Phase: N/A
Study type: Interventional

An 8-week yoga intervention to determine the feasibility and acceptability of yoga as a supplemental therapy in the management of inflammatory bowel disease in the adolescent population.

NCT ID: NCT04757805 Completed - Anesthesia, Local Clinical Trials

Accuracy of Manual Palpation vs Ultrasound for Spinal Anesthesia

Start date: May 6, 2021
Phase: N/A
Study type: Interventional

Although the current standard for lumbar puncture and spinal anesthesia is the use of manual palpation of surface landmarks to identify the correct interspace, performance of the procedure at too high of a level may increase the incidence of adverse effects. The current study will evaluate the efficacy of ultrasound in identifying the correct intervertebral space for lumbar puncture thereby improving the safety of the procedure.

NCT ID: NCT04757662 Completed - Clinical trials for Astrocytoma, Grade IV

Tadalafil to Overcome Immunosuppression During Chemoradiotherapy for IDH-wildtype Grade III-IV Astrocytoma

Start date: May 14, 2021
Phase: Phase 1
Study type: Interventional

Increasing preclinical and clinical data have shown that myeloid-derived suppressor cells (MDSCs) may represent a significant driver of immunosuppression in glioblastoma (GBM, grade IV astrocytoma) and a potential mechanism of treatment resistance to chemoradiotherapy. Tadalafil, an FDA-approved drug with inexpensive cost and excellent safety profile, has been shown to effectively reduce MDSCs and restore T-cell activation in the peripheral blood and in the tumor microenvironment. The purpose of this study is to investigate the impact of targeting MDSCs in newly diagnosed IDH-wildtype grade III-IV astrocytoma by combining tadalafil with standard of care radiation therapy (RT) and temozolomide (TMZ).

NCT ID: NCT04757649 Completed - Suicide Clinical Trials

Suicide Prevention for Sexual and Gender Minority Youth (Case Series)

Start date: May 13, 2021
Phase: N/A
Study type: Interventional

The overarching goal of this study is to develop a suicide prevention program for sexual-and-gender-minority youth and emerging adults. After development of the intervention program, a case series trial will be conducted to test the feasibility and acceptability of the intervention and study methods.

NCT ID: NCT04757584 Completed - Heart Failure Clinical Trials

Pilot Deprescribing N-of-1 Trials for Beta-blockers in HFpEF

Start date: April 1, 2021
Phase: Phase 4
Study type: Interventional

In this study, we will test the feasibility of N-of-1 trials for deprescribing beta-blockers in patients with Heart Failure with Preserved Ejection Fraction. To achieve this objective we will conduct 16 4-period N-of-1 trials (on vs. off) and subsequently interview participants to better understand feasibility and pragmatism. The N-of-1 trials will be iteratively refined in real-time based on this feedback.

NCT ID: NCT04757298 Completed - COVID-19 Testing Clinical Trials

Optimization of a New Adaptive Intervention to Increase COVID-19 Testing

Start date: February 12, 2021
Phase: N/A
Study type: Interventional

This study tests an adaptation of the HIV Continuum of Prevention, Care, and Treatment Framework (CoPCT) for use in tracking COVID-19 testing and follow-up in a medically and socially vulnerable population. This study uses an integrated research collaborative framework that facilitates dialogue among researchers, community members, and service providers as a tool for optimizing the adaptive intervention and will take place at the North Jersey Community Research Initiative (NJCRI)

NCT ID: NCT04757233 Completed - Clinical trials for Type 2 Diabetes Mellitus

Personalizing Self-management in Diabetes - Pilot Study

Start date: February 1, 2018
Phase: N/A
Study type: Interventional

The goal of this study is to conduct a pilot feasibility study a novel informatics intervention, GlucoType (also called Platano for Latino users) that incorporates computational analysis of self-monitoring data to help individuals with type 2 diabetes personalize diabetes self-management strategies. This study will include 20 individuals with type 2 diabetes mellitus (T2DM) recruited from economically disadvantaged and medically underserved communities to test Platano for 4 weeks to assess its acceptability and feasibility. The main outcome measures include problem-solving abilities in diabetes (Diabetes Problem-Solving Inventory (DPSA)) and self-reported diabetes self-care (Summary of Diabetes Self-Care Activities Questionnaire (SDSCA)). In addition, this study will include a controlled laboratory experiment to assess whether participants can understand and follow personalized nutritional goals generated by Platano.

NCT ID: NCT04757181 Completed - Clinical trials for Inflammatory Bowel Diseases

The Inflammatory Bowel Disease - Anti-Inflammatory Diet (IBD-AID)

IBD-AID
Start date: February 1, 2017
Phase: N/A
Study type: Interventional

The goal of this study is to prospectively test the hypothesis that specific dietary modification can improve patient symptoms by promoting beneficial changes in the composition of the microbiome that, in turn, alter the immune response in such a way as to and ameliorate inflammatory conditions such as Inflammatory Bowel Disease (IBD). The potential long term benefit of this research is a validated set of efficacious dietary guidelines for persons with IBD. The potential immediate benefit to patients is symptomatic relief and healing.